Company profile
Zenith Capital Corp.
OTC: ZHCLF · Healthcare · Biotechnology
Canadian filerHQ Calgary, ABReports USD
#932 of 1,418 Healthcare companies by revenue
EA Score
——FH —DQ —GM —SS 56
v0.1 · 5/100 weight · pillars only
↑ workforce scale, disclosure history · ↓ Piotroski F, listing tenure
Methodology →Revenue TTM
$500.0k
Rev growth YoY (TTM)
needs 8 qtrs
Net income (FY)
-$7.3M
Employees
50,477
as of 2026-08-30
Market cap
$16.0M
as of 2026-08-30
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$500.0k$500.0k2024
Net income-$7.3M-$7.3M2024
Operating income-$4.8M-$4.8M2024
Total assets$0$02024
Liabilities$0$02024
Equity$0$02024
Revenue trend
FY2017 – FY2024 · USD
FY17
FY18
FY19
FY20
FY21
FY22
FY23
FY24
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Zenith Capital Corp.’s revenue?
Zenith Capital Corp. booked $500.0k in FY2024 revenue — among the slowest-growing Healthcare companies we track, at a -1469.8% net margin.
Peers · Healthcare
Sibannac, Inc.——Medivolve Inc.——DiaMedica Therapeutics Inc.35DImunon, Inc.39DBioelectronics Corporation——Pasithea Therapeutics Corp.32DKey facts
CEODonald J. McCaffrey
SectorHealthcare
IndustryBiotechnology
HeadquartersCalgary, AB
ExchangeOTC: ZHCLF
Employees50,477
IPO date2021-05-28
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.